Dicerna Pharmaceuticals
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Website
www.uncoveringph.comRevenue
$7.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Dicerna Pharmaceuticals
Novo Nordisk specializes in providing information and resources related to Primary Hyperoxaluria (PH), a rare genetic disorder that leads to kidney damage due to hepatic oxalate overproduction. Their services are aimed at healthcare professionals in the U.S., offering insights into the diagnosis, management, and understanding of PH and its various subtypes. The company emphasizes the importance of accurate diagnosis and management strategies for patients suffering from this condition. Through their platform, they aim to enhance awareness and provide tools for healthcare providers dealing with genetic kidney stone diseases.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Dicerna Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Dicerna Pharmaceuticals is spiking on competitors!
Funding: Get notified immidiatlly once Dicerna Pharmaceuticals has new funding data
Click to see if Dicerna Pharmaceuticals had a recent Job posting/layoffs
Earning: See what the market has to say on Dicerna Pharmaceuticals recently announced quarterly report
Dicerna Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Dicerna Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Dicerna Pharmaceuticals launches new products
Congratulate Masked Content for being promoted to Masked Content at Dicerna Pharmaceuticals
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Dicerna Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to Dicerna Pharmaceuticals
Compare insights from companies similar to Dicerna Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Dicerna Pharmaceuticals
$7.2M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Dicerna Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Dicerna Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Dicerna Pharmaceuticals.
Dicerna Pharmaceuticals Tech Stack
A closer look at the technologies used by Dicerna Pharmaceuticals
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Dicerna Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Novo Nordisk specializes in providing information and resources related to Primary Hyperoxaluria (PH), a rare genetic disorder that leads to kidney damage due to hepatic oxalate overproduction. Their services are aimed at healthcare professionals in the U.S., offering insights into the diagnosis, management, and understanding of PH and its various... Read More
